Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Moderately high prolactin levels do not cause hair loss in women.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Azelaic Acid is effective and safe for treating adult female acne, with few side effects.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.